Silvia de Sanjosé, premio Jaume I 2025 a la Investigación Clínica y la Salud Pública

Silvia de Sanjosé, Epidemioga specialized in the Human Papillomavirus (HPV) and in associated cancer an east, Has been awarded the Jaume I Prize in the category of clinical research and public health.

With 35 years of experience, Isglobal’s research is also an associated professor at the University of Washington and Medical of Primary Attention. In 1992, he was one of the first scientists to thirsty Relationship between HPV and uterine cult cancerA finding that would mark the Run Run Run Carrera.

Since then, he has focused his research on HPV study, participating in International Genotipific Investigations of the virus and contributing to the development of the guides of Cervical cancer screening Based on HPV both in Spain and in Catalonia.

«90 % of HPV’s cases previous son,» says Sanjosé. «To eradicate the uterine ass carcinoma, it is crossing to foster HPV vaccination among young women, and Spain has become an exemplary country in this aspego,» he adds.

In the previous edition, all the winners; Sin embargo, this year Four of the seven awards have fallen to researchersMarking an advance towards a mayor represent the female in science. With this recognition, Silvia de Sanjosé becomes the second person of the Upplobal In receiving this prestigious award. In 2024, in the first edition of the Public Health Research Award, the award -winning was also the epidemiologist of Isglobal Jordi Sunyer.

Estaremos encantados de escuchar lo que piensas

Deje una respuesta

GangaSpain
Logo
Registrar una cuenta nueva
Comparar artículos
  • Total (0)
Comparar
0
GangaSpain
Shopping cart